Hollencrest Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.46M | Sell |
5,785
-502
| -8% | -$108K | 0.09% | 124 |
|
|
2026
Q1 | $1.37M | Hold |
6,287
| – | – | 0.05% | 133 |
|
|
2025
Q4 | $1.44M | Buy |
6,287
+302
| +5% | +$68.8K | 0.05% | 126 |
|
|
2025
Q3 | $1.39M | Hold |
5,985
| – | – | 0.05% | 130 |
|
|
2025
Q2 | $1.11M | Hold |
5,985
| – | – | 0.05% | 132 |
|
|
2025
Q1 | $1.25M | Sell |
5,985
-4
| -0.1% | -$778 | 0.05% | 128 |
|
|
2024
Q4 | $1.06M | Sell |
5,989
-232
| -4% | -$42.7K | 0.04% | 143 |
|
|
2024
Q3 | $1.23M | Sell |
6,221
-315
| -5% | -$58.8K | 0.05% | 134 |
|
|
2024
Q2 | $1.12M | Hold |
6,536
| – | – | 0.05% | 134 |
|
|
2024
Q1 | $1.19M | Sell |
6,536
-10
| -0.2% | -$1.72K | 0.05% | 128 |
|
|
2023
Q4 | $1.01M | Sell |
6,546
-7
| -0.1% | -$1.02K | 0.1% | 122 |
|
|
2023
Q3 | $977K | Hold |
6,553
| – | – | 0.11% | 110 |
|
|
2023
Q2 | $883K | Buy |
6,553
+152
| +2% | +$22.3K | 0.09% | 125 |
|
|
2023
Q1 | $1.02M | Buy |
6,401
+56
| +0.9% | +$8.56K | 0.11% | 108 |
|
|
2022
Q4 | $1.03M | Buy |
6,345
+246
| +4% | +$37.7K | 0.13% | 97 |
|
|
2022
Q3 | $818K | Sell |
6,099
-100
| -2% | -$14.3K | 0.1% | 102 |
|
|
2022
Q2 | $950K | Hold |
6,199
| – | – | 0.11% | 103 |
|
|
2022
Q1 | $1M | Sell |
6,199
-3,300
| -35% | -$479K | 0.09% | 114 |
|
|
2021
Q4 | $1.29M | Buy |
9,499
+1,490
| +19% | +$176K | 0.1% | 102 |
|
|
2021
Q3 | $864K | Buy |
8,009
+800
| +11% | +$91.4K | 0.08% | 133 |
|
|
2021
Q2 | $812K | Buy |
7,209
+200
| +3% | +$22.5K | 0.07% | 140 |
|
|
2021
Q1 | $759K | Sell |
7,009
-6,253
| -47% | -$669K | 0.07% | 144 |
|
|
2020
Q4 | $1.42M | Sell |
13,262
-98
| -0.7% | -$9.42K | 0.15% | 85 |
|
|
2020
Q3 | $1.17M | Sell |
13,360
-111
| -0.8% | -$10.4K | 0.14% | 90 |
|
|
2020
Q2 | $1.32M | Buy |
13,471
+4
| +0% | +$352 | 0.18% | 76 |
|
|
2020
Q1 | $1.03M | Buy |
13,467
+849
| +7% | +$72.3K | 0.15% | 89 |
|
|
2019
Q4 | $1.12M | Buy |
12,618
+4
| +0% | +$332 | 0.13% | 101 |
|
|
2019
Q3 | $955K | Sell |
12,614
-394
| -3% | -$27K | 0.12% | 112 |
|
|
2019
Q2 | $946K | Buy |
13,008
+5
| +0% | +$393 | 0.12% | 117 |
|
|
2019
Q1 | $1.05M | Buy |
13,003
+5
| +0% | +$409 | 0.14% | 101 |
|
|
2018
Q4 | $1.2M | Sell |
12,998
-13,000
| -50% | -$1.14M | 0.18% | 85 |
|
|
2018
Q3 | $2.28M | Buy |
25,998
+23,256
| +848% | +$2.21M | 0.15% | 96 |
|
|
2018
Q2 | $255K | Sell |
2,742
-616
| -18% | -$60.2K | 0.03% | 223 |
|
|
2018
Q1 | $318K | Buy |
3,358
+4
| +0.1% | +$439 | 0.04% | 206 |
|
|
2017
Q4 | $324K | Sell |
3,354
-3,796
| -53% | -$358K | 0.04% | 210 |
|
|
2017
Q3 | $635K | Buy |
7,150
+6
| +0.1% | +$457 | 0.09% | 143 |
|
|
2017
Q2 | $518K | Buy |
7,144
+5
| +0.1% | +$336 | 0.08% | 159 |
|
|
2017
Q1 | $465K | Buy |
+7,139
| New | +$449K | 0.07% | 188 |
|
|
2016
Q4 | – | Sell |
-10,919
| Closed | -$689K | – | 336 |
|
|
2016
Q3 | $689K | Buy |
10,919
+82
| +0.8% | +$5.31K | 0.1% | 146 |
|
|
2016
Q2 | $671K | Sell |
10,837
-156
| -1% | -$9.51K | 0.1% | 154 |
|
|
2016
Q1 | $628K | Buy |
10,993
+1,007
| +10% | +$56.1K | 0.11% | 150 |
|
|
2015
Q4 | $591K | Buy |
9,986
+1,106
| +12% | +$63.7K | 0.1% | 167 |
|
|
2015
Q3 | $483K | Sell |
8,880
-1,956
| -18% | -$127K | 0.08% | 174 |
|
|
2015
Q2 | $728K | Sell |
10,836
-4,416
| -29% | -$288K | 0.1% | 134 |
|
|
2015
Q1 | $893K | Buy |
15,252
+182
| +1% | +$11K | 0.12% | 126 |
|
|
2014
Q4 | $986K | Buy |
15,070
+1,779
| +13% | +$112K | 0.13% | 120 |
|
|
2014
Q3 | $767K | Buy |
13,291
+5,405
| +69% | +$300K | 0.1% | 132 |
|
|
2014
Q2 | $445K | Buy |
7,886
+3,152
| +67% | +$165K | 0.06% | 212 |
|
|
2014
Q1 | $244K | Buy |
4,734
+852
| +22% | +$43.1K | 0.04% | 317 |
|
|
2013
Q4 | $205K | Buy |
+3,882
| New | +$191K | 0.03% | 301 |
|
Other funds holding ABBV
Hollencrest Capital Management's ABBV Position: Q2 2026 in Review
Hollencrest Capital Management reduced its AbbVie (ABBV) stake by 8% in Q2 2026, selling an estimated $108K and leaving 5,785 shares worth $1.46M. The position accounts for 0.09% of the portfolio, ranked #124.
Hollencrest Capital Management first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.28M in Q3 2018. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hollencrest Capital Management held 5,785 shares of AbbVie worth $1.46M as of Q2 2026.
- Hollencrest Capital Management sold 502 AbbVie shares in Q2 2026, an estimated $108K.
- AbbVie made up 0.09% of Hollencrest Capital Management's portfolio in Q2 2026, its #124 holding.
- Hollencrest Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
- Hollencrest Capital Management's AbbVie position peaked at $2.28M in Q3 2018.
- 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.